Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis

被引：61

作者：

Pavie, J

Lacroix, C

Hermoso, DG

Robin, M

Ferry, C

Bergeron, A

Feuilhade, M

Dromer, F

Gluckman, E

Molina, JM

Ribaud, P

机构：

[1] Hop St Louis, Serv Hematol Greffe Moelle, F-75475 Paris, France

[2] Hop St Louis, Serv Malad Infect & Trop, F-75475 Paris, France

[3] Hop St Louis, Lab Parasitol Mycol, F-75475 Paris, France

[4] Hop St Louis, Serv Pneumol, F-75475 Paris, France

[5] Inst Pasteur, Ctr Natl Reference Mycol & Antifong, Unite Mycol Mol, CNRS FRE 2849, Paris, France

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2005年 / 43卷 / 09期

关键词：

D O I：

10.1128/JCM.43.9.4902-4904.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Aspergillus ustus is an uncommon clinical species which is poorly susceptible to antifungals. We report two cases of A. ustus infections that occurred in allogeneic stem cell transplant recipients while they were receiving either voriconazole or caspofungin. Prolonged use of these new antifungal agents may increase the risk of the emergence of resistant organisms.

引用

收藏

页码：4902 / 4904

页数：3

相关论文

共 16 条

[1] In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates [J].

Arikan, S ;

Lozano-Chiu, M ;

Paetznick, V ;

Rex, JH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :327-330

[2] Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus [J].

Ascioglu, S ;

Rex, JH ;

de Pauw, B ;

Bennett, JE ;

Bille, J ;

Crokaert, F ;

Denning, DW ;

Donnelly, JP ;

Edwards, JE ;

Erjavec, Z ;

Fiere, D ;

Lortholary, O ;

Maertens, J ;

Meis, JF ;

Patterson, TF ;

Ritter, J ;

Selleslag, D ;

Shah, PM ;

Stevens, DA ;

Walsh, TJ .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :7-14

[3] Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection [J].

Azzola, A ;

Passweg, JR ;

Habicht, JM ;

Bubendorf, L ;

Tamm, M ;

Gratwohl, A ;

Eich, G .

JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (10) :4805-4808

[4] Invasive mold infections in allogeneic bone marrow transplant recipients [J].

Baddley, JW ;

Stroud, TP ;

Salzman, D ;

Pappas, PG .

CLINICAL INFECTIOUS DISEASES, 2001, 32 (09) :1319-1324

[5] Serum Aspergillus galactomannan antigen testing by sandwich ELISA: Practical use in neutropenic patients [J].

Bretagne, S ;

MarmoratKhuong, A ;

Kuentz, M ;

Latge, JP ;

BartDelabesse, E ;

Cordonnier, C .

JOURNAL OF INFECTION, 1997, 35 (01) :7-15

[6] Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species [J].

Cuenca-Estrella, M ;

Lee-Yang, W ;

Ciblak, MA ;

Arthington-Skaggs, BA ;

Mellado, E ;

Warnock, DW ;

Rodriguez-Tudela, JL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) :3644-3647

[7] Cutaneous infection caused by Aspergillus ustus, an emerging opportunistic fungus in immunosuppressed patients [J].

Gené, J ;

Azón-Masoliver, A ;

Guarro, J ;

De Febrer, G ;

Martínez, A ;

Grau, C ;

Ortoneda, M ;

Ballester, F .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (03) :1134-1136

[8] Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis [J].

Herbrecht, R ;

Denning, DW ;

Patterson, TF ;

Bennett, JE ;

Greene, RE ;

Oestmann, JW ;

Kern, WV ;

Marr, KA ;

Ribaud, P ;

Lortholary, O ;

Sylvester, R ;

Rubin, RH ;

Wingard, JR ;

Stark, P ;

Durand, C ;

Caillot, D ;

Thiel, E ;

Chandrasekar, PH ;

Hodges, MR ;

Schlamm, HT ;

Troke, PF ;

de Pauw, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :408-415

[9] Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole [J].

Imhof, A ;

Balajee, SA ;

Fredricks, DN ;

Englund, JA ;

Marr, KA .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (05) :743-746

[10] Disseminated aspergillosis caused by Aspergillus ustus in a patient following allogeneic peripheral stem cell transplantation [J].

Iwen, PC ;

Rupp, ME ;

Bishop, MR ;

Rinaldi, MG ;

Sutton, DA ;

Tarantolo, S ;

Hinrichs, SH .

JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (12) :3713-3717